It has previously been shown that TNKS inhibition sensitizes KRAS mutant cancer cells to growth inhibition by MEK inhibitors [13], also in cell lines whose proliferation rate is unaffected by single TNKS inhibitor treatment [14]. The gene discussed is KRAS; the disease is cancer.